The stock's overall trend over the past six months has been volatile but ultimately negative, declining 5.52% from October 2025 to March 2026. The price peaked at $167.20 in late February before a sharp correction. Short-term performance shows significant weakness, with the stock down 13.45% over the past month, underperforming the S&P 500 by 5.58 percentage points. However, it has shown relative strength over three months, gaining 0.47% while the broader market fell 7.32%. The current price of $144.72 sits near the lower end of its 52-week range of $137.62 to $174.80, approximately 17% below its yearly high. This suggests the stock is in a corrective phase after its recent peak.

Revenue growth has been modest but stable, with Q2 2026 revenue of $22.21 billion representing a 1.5% year-over-year increase. Profitability remains strong, with a net margin of 19.5% for the quarter, though this is down from 21.2% in the prior quarter, indicating some margin pressure. The company maintains a solid financial position with a debt-to-equity ratio of 0.68, indicating moderate leverage. Cash flow generation is robust, with free cash flow over the trailing twelve months at $14.85 billion, providing ample coverage for dividends and share repurchases. Operational efficiency is highlighted by a strong return on equity of 30.7%, demonstrating effective use of shareholder capital. The current ratio of 0.70 suggests adequate, though not excessive, liquidity to meet short-term obligations.